发明名称 |
Imidazolothiazole compounds for the treatment of disease |
摘要 |
Compounds, compositions and methods are provided for modulating the activity of receptor kinases and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by receptor kinases. |
申请公布号 |
US8921546(B2) |
申请公布日期 |
2014.12.30 |
申请号 |
US201314033299 |
申请日期 |
2013.09.20 |
申请人 |
Ambit Biosciences Corporation |
发明人 |
Chao Qi |
分类号 |
C07D513/04 |
主分类号 |
C07D513/04 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A compound selected from (7-(2-morpholin-4-yl-ethoxy)-2-(4-nitro-phenyl)imidazo[2,1-b][1,3]benzothiazole) and 4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)aniline. |
地址 |
San Diego CA US |